Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Revenue

Fate Therapeutics had revenue of $1.63M in the quarter ending March 31, 2025, a decrease of -15.38%. This brings the company's revenue in the last twelve months to $13.34M, up 105.85% year-over-year. In the year 2024, Fate Therapeutics had annual revenue of $13.63M, down -78.55%.

• Revenue (ttm): $13.34M
• Revenue Growth: +105.85%
• P/S Ratio: 9.20
• Revenue / Employee: $73,674
• Employees: 181
• Market Cap: 119.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	13.63M	-49.90M	-78.55%
Dec 31, 2023	63.53M	-32.77M	-34.03%
Dec 31, 2022	96.30M	40.45M	72.44%
Dec 31, 2021	55.85M	24.41M	77.66%
Dec 31, 2020	31.43M	20.75M	194.33%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.